Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis
Abstract Background The non-invasive Cxbladder urine test system has demonstrated clinical utility in ruling out urothelial carcinoma (UC) in patients with asymptomatic microscopic hematuria (AMH), suggesting that the number of invasive diagnostic tests, including cystoscopy, used in this patient po...
Main Authors: | Tony Lough, Qingyang Luo, Carthika Luxmanan, Alastair Anderson, Jimmy Suttie, Paul O’Sullivan, David Darling |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12894-018-0327-6 |
Similar Items
-
Comparison of Ultrasonography and Cystoscopy in the Evaluation of Hematuria
by: Bahadır Topuz, et al.
Published: (2019-03-01) -
Risk stratification and diagnostic evaluation of patients found to have microscopic hematuria by their primary care providers
by: Clemens An, et al.
Published: (2025-01-01) -
Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer—A Pilot Study
by: Kaoru Murakami, et al.
Published: (2022-01-01) -
Cases of a Borderline Pathology That Can Mimic Bladder Cancer: Primary Amyloidosis of Urinary Bladder
by: Cemal Selçuk İşoğlu, et al.
Published: (2015-06-01) -
Youssef’s syndrome - a need to review our ways
by: Pranay Kr Phukan, et al.
Published: (2022-07-01)